earnings
confidence high
sentiment positive
materiality 0.75
Omnicell Q3 revenue $282M (-5% YoY); raises FY2024 non-GAAP EBITDA & EPS guidance
OMNICELL, INC.
2024-Q3 EPS reported
-$0.07
revenue$805,359,000
- Q3 GAAP net income $9M ($0.19/diluted) vs. $6M ($0.12) YoY; non-GAAP EPS $0.56 vs. $0.62.
- Total revenues $282M, down 5% YoY due to health system headwinds and XT Series cycle timing.
- FY2024 guidance raised: non-GAAP EBITDA $129-134M, non-GAAP EPS $1.65-1.72.
- Appointed Nnamdi Njoku as EVP & COO; cash $571M, $350M revolver undrawn.
- Q4 2024 revenue guidance $295-305M; non-GAAP Q4 EPS $0.55-0.62.